EL AL ISRAEL AIRLINES LTD. (ELAL)
Register of shareholders, changes and capital status
Register of shareholders, changes and capital status
Private offering
Dormant shares
Events and transactions
Dividend in kind
dividend
Management and officers – staffing as of 27.3.26
The company’s liability position as of 31.12.25, by maturity dates
Periodic and annual report for 2025
Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million